Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXHT1E
|
||||
| Drug Name |
[(S)-1-((R)-1-Phenyl-ethylaminooxalyl)-pentyl]-carbamic acid bicyclo[2.2.1]hept-2-yl ester
|
||||
| Synonyms |
CHEMBL196298
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H32N2O4
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)OC1CC2CCC1C2)C(=O)C(=O)N[C@H](C)c3ccccc3
|
||||
| InChI |
InChI=1S/C23H32N2O4/c1-3-4-10-19(25-23(28)29-20-14-16-11-12-18(20)13-16)21(26)22(27)24-15(2)17-8-6-5-7-9-17/h5-9,15-16,18-20H,3-4,10-14H2,1-2H3,(H,24,27)(H,25,28)/t15-,16?,18?,19+,20?/m1/s1
|
||||
| InChIKey |
HMVXEHSUUNUEBL-BEMVKYSYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.